Khara Ramos is director of the Neuroethics Program, and health scientist administrator in the Office of Scientific Liaison, at the National Institute of Neurological Disorders and Stroke.
![Portrait of Khara Ramos](https://www.thetransmitter.org/wp-content/uploads/2019/10/KahraRamos_140x170_0.jpg)
Khara Ramos
Director, Neuroethics Program
National Institute of Neurological Disorders and Stroke
From this contributor
U.S. initiative grapples with ethical questions on brain research
Khara Ramos explains how the Brain Initiative incorporates the emerging field of ‘neuroethics’ into the research it funds.
![Cerebellum brain cells, light micrograph.](https://www.thetransmitter.org/wp-content/uploads/2019/10/NeuroEthics844.jpg)
U.S. initiative grapples with ethical questions on brain research
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.